Lee Kalowski's Net Worth
$3.42 Million
Who is Lee Kalowski?
Lee Kalowski has an estimated net worth of $3.42 Million. This is based on reported shares across multiple companies, which include BICYCLE THERAPEUTICS plc, Tokai Pharmaceuticals Inc, and Homology Medicines, Inc..
SEC CIK
Lee Kalowski's CIK is 0001618273
Past Insider Trading and Trends
2021 was Lee Kalowski's most active year for acquiring shares with 8 total transactions. Lee Kalowski's most active month to acquire stocks was the month of December. 2021 was Lee Kalowski's most active year for disposing of shares, totalling 16 transactions. Lee Kalowski's most active month to dispose stocks was the month of October. 2021 saw Lee Kalowski paying a total of $244,646.50 for 134,000 shares, this is the most they've acquired in one year. In 2021 Lee Kalowski cashed out on 127,000 shares for a total of $2,040,187.06, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BICYCLE THERAPEUTICS plc (BCYC) Snapshot price: $20.54
President and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.23% | -376.00 |
$21.11 | -$7,937.36 | 30.31K |
Apr 3
| |||
Form 4
| +104.57% | 15.69K |
$29.06 | -$52,743.90 | 30.68K |
Jan 3
| |||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Jan 3
| |||
Form 4
|
—
|
0
|
$24.91 | -$301,800.00 |
0
|
Scheduled
|
Sep 2
| ||
Form 4
|
—
|
0
|
$21.94 | -$224,493.00 |
0
|
Scheduled
|
Aug 26 - Aug 27
| ||
Form 4
|
—
|
0
|
$17.31 | -$235,650.00 |
0
|
Scheduled
|
Aug 23
| ||
Form 4
|
—
|
0
|
$16.57 | -$373,447.56 |
0
|
Scheduled
|
Jul 29
| ||
Form 4
|
—
|
0
|
$15.80 | -$426,150.00 |
0
|
Scheduled
|
Jan 19
| ||
Form 4
|
—
|
0
|
$13.30 | -$234,000.00 |
0
|
Scheduled
|
Jan 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
$12.03 | -$157,050.00 |
0
|
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$10.78 | -$9,773.20 |
0
|
Scheduled
|
Nov 27
| ||
Form 4
|
—
|
0
|
$10.74 | -$495,036.73 |
0
|
Scheduled
|
Nov 23 - Nov 25
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tokai Pharmaceuticals Inc (ELDN) Snapshot price: $2.664
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
| -10.23% | -4.67K |
$13.13 | -$61,290.84 | 40.95K |
Scheduled
|
Sep 8
| ||
Form 4
| -4.52% | -2.16K |
$12.96 | -$27,967.68 | 45.62K |
Scheduled
|
Sep 2
| ||
Form 4
| -8.72% | -4.57K |
$13.00 | -$59,371.00 | 47.78K |
Scheduled
|
Apr 16
| ||
Form 4
| -4.14% | -2.26K |
$11.45 | -$25,854.10 | 52.35K |
Scheduled
|
Apr 2
| ||
Form 4
|
∞
| 54.6K |
—
|
—
| 54.6K |
Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Homology Medicines, Inc. (FIXX) No price found
CFO and President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||